Skip to main content

LCD L33967: Vitamin B<sub>12</sub> Injections

LCD L33967, Vitamin B<sub>12</sub> Injections, is the Local Coverage Determination that First Coast Service Options, Inc. applies to claims from 3 states (FL, PR, VI), effective 2021-01-01 and first in force 2015-10-01. The policy text runs 289 words, and its billing and coding article A57755 lists 44 ICD-10-CM codes that support medical necessity for 2 procedure codes. No other contractor publishes a policy with this title.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database LCD export release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (Thursdays) for the MCD.
Contractor
First Coast Service Options, Inc.
States and territories
3
FL PR VI
Revision effective
2021-01-01
Original effective
2015-10-01
Policy text
289 words
Covered ICD-10 codes (articles)
44

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33967
ContractContractorTypeStates
09102First Coast Service Options, Inc.A and B MACFL
09202First Coast Service Options, Inc.A and B MACPR
09302First Coast Service Options, Inc.A and B MACVI

Billing and coding: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A57755 (Billing and Coding: Vitamin B<sub>12</sub> Injections) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown.

A57755: Billing and Coding: Vitamin B<sub>12</sub> Injections (Billing and Coding, effective 2024-04-01)

Covered ICD-10-CM codes
44
1 group
Non-covered ICD-10-CM codes
1
Procedure codes listed
2
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A57755
ICD-10-CMDescription (FY2027)
D51.0—
D51.1—
D51.2—
D51.3—
D51.8—
D51.9—
D52.0—
D52.1—
D52.8—
D52.9—
D53.1—
D53.9—
D81.818—
D81.819—
E40Kwashiorkor
E41Nutritional marasmus
E42Marasmic kwashiorkor
E44.1—
E45Retarded development following protein-calorie malnutrition
E46Unspecified protein-calorie malnutrition
E53.8—
E64.0—
G32.0—
K29.30—

Procedure codes: J3420 (Injection, Vitamin B-12 Cyanocobalamin, Up To 1000 Mcg), J3425 (Injection, Hydroxocobalamin, Intramuscular, 10 Mcg).

Coverage indications, limitations and medical necessity

Compliance with the provisions in this LCD may be monitored and addressed through post payment data analysis and subsequent medical review audits.

History/Background and/or General Information

Vitamin B 12 is essential for the formation of red blood cells and is used in the treatment of diseases in which there is defective red cell formation.

Covered Indications

Vitamin B 12 injection will be considered medically reasonable and necessary under the following circumstances:

• Vitamin B 12 administration by injection is a covered benefit accepted as medically necessary when the beneficiary has a history of a low serum B 12 or conditions causing or caused by a low serum B 12 .

In addition, vitamin B 12 will be considered medically reasonable and necessary when administered as an adjunct to pemetrexed or pralatrexate treatment as follows:

• For pemetrexed patients, patients must receive one intramuscular injection of vitamin B 12 during the week preceding the first dose of pemetrexed and every three cycles thereafter

• For pralatrexate patients, supplement patients with vitamin B 12 1 mg intramuscularly no more than 10 weeks prior to the first dose of pralatrexate, and every 8-10 weeks thereafter

Subsequent vitamin B 12 injections may be given the same day as either pemetrexed or pralatrexate.

Limitations

Please refer to CMS IOM Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 2, Section 150.6 Vitamin B 12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot regarding non coverage.

Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.

Summary of evidence (opening)

N/A

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2021-01-01
Last reviewed by the contractor
2018-04-25
MCD version
25
Derived from
L29309

The contractor lists one National Coverage Determination as related: NCD 150.6 Vitamin B12 Injections to Strengthen Tendons, Ligaments, etc., of the Foot. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line, and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the First Coast Service Options, Inc. hub lists every other active policy from the same contractor.

Frequently asked questions

What does LCD L33967 cover?

Vitamin B 12 is essential for the formation of red blood cells and is used in the treatment of diseases in which there is defective red cell formation. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database export of September 24, 2026.

Which states does LCD L33967 apply to?

First Coast Service Options, Inc. applies it to Medicare claims in FL, PR, VI. A Local Coverage Determination binds only the contractor that wrote it; the same service in another jurisdiction is judged under that contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33967?

The companion billing and coding article A57755 lists 44 ICD-10-CM codes in 1 group that support medical necessity and 1 that do not; the first 24 appear on this page and the complete list is in the article on cms.gov.

How do I appeal a denial under LCD L33967?

The remittance carries claim adjustment reason code 50 with remark code N115, naming the LCD. Compare the documented indication with the policy's covered indications and the article's diagnosis list, then file a redetermination within 120 days with the record attached; if the service genuinely falls outside the policy, the patient can be billed only when a valid Advance Beneficiary Notice was obtained before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.